Picture of Vericel logo

VCEL — Vericel News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Vericel Corp reports results for the quarter ended in September - Earnings Summary

* Vericel Corp  VCEL.OQ  reported a quarterly adjusted loss
of 11 cents​​ per share for the quarter ended in September. The
mean expectation of seven analysts for the quarter was for a
loss of 3 cents per share.
* Revenue rose 4.5% to $33.72 million from a year ago;  analysts
expected $38.07 million. 
* Vericel Corp's reported EPS for the quarter was a loss of 11
cents​.
* The mean earnings estimate of analysts had fallen by about 67%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Vericel Corp shares had fallen by 11.7% this quarter and
gained 39.6% so far this year.
* The company reported a quarterly loss of $4.93 million.
* Wall Street's median 12-month price target for Vericel Corp is
$65.13 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 9 at 01:36 p.m.
 ​All figures in US dollars unless otherwise stated

Recent news on Vericel

See all news